Computer Vision Systems Laboratories has executed an agreement with Infrared Sciences to license the rights, title and interest in the intellectual property surrounding the Sentinel BreastScan.
The Sentinel BreastScan is an infrared breast imaging system used as an adjunctive modality by physicians specializing in breast imaging and breast cancer treatment.
The agreement will give Computer Vision exclusive rights to manufacture and supply the system throughout the world. It will also give the company the rights to the system's FDA 510(k) clearance and to transfer its CE mark for marketing within the European Union.
Computer Vision filed an 8k with the Securities and Exchange Commission detailing the agreement on July 14.